not tagged
abbvie,genmab
['lymphoma', '$gmab', '$abbv', 'abbvie']
abbvie, genmab bispecific shows cr rate of at least 34% in lymphoma trial $abbv $gmab #eha22 
#IME #CME #healthcare #innovation #DotConnector https://t.co/Ag09XUbNP3